• UK’s £225m AI supercomputer, Isambard-AI, launches in Bristol
    Thursday, July 17, 2025 from Cancer | The Guardian
    Hopes £225m Isambard-AI in Bristol will unleash new era of technological, medical and social breakthroughs Britain’s new £225m national artificial intelligence supercomputer will be used to spot sick dairy cows in Somerset, improve the...
  • Genetic mutations in prostate cancer can differ significantly based on race, ethnicity
    Wednesday, July 16, 2025 from Healio.com HEMATOLOGY ONCOLOGY RSS Feed
    Prostate cancer tumor biology can differ significantly based on whether a patient is Black or white, according to data from a genomic profiling study of more than 5,000 veterans. Black men had higher odds of alterations in immunotherapy...
  • Light exercise lowers cancer risk
    Wednesday, July 16, 2025 from Healio.com HEMATOLOGY ONCOLOGY RSS Feed
    Engaging in light-intensity physical activity, such as casual walking or household chores, may lower the risk for certain types of cancer, according to study results published in British Journal of Sports Medicine. Individuals who took...
  • ‘I was raped. And my dreams were shattered’ – Gina Miller on abuse, cancer and the toxic race for Cambridge chancellor
    Wednesday, July 16, 2025 from Cancer | The Guardian
    She is the activist who fought against Boris Johnson’s Brexit deal. Now she’s vying to be the university’s first female chancellor – all while going through chemotherapy. She talks about the attack that destroyed her own student years My...
  • Study launches to assess blood tests for early cancer detection
    Tuesday, July 15, 2025 from Healio.com HEMATOLOGY ONCOLOGY RSS Feed
    A national pilot study designed to determine if blood tests can help detect cancers earlier is open for enrollment. Results of the Vanguard Study — which will include up to 24,000 people — also will provide insights into the feasibility...
  • Symptom awareness, risk models key to detecting early onset CRC
    Tuesday, July 15, 2025 from Healio.com HEMATOLOGY ONCOLOGY RSS Feed
    Editor’s Note: This story is part of a Healio Exclusive series about early-onset colorectal cancer. This installment explores the primary care provider’s role in early detection. Other stories in this series focus on screening, new...
  • Weight-loss wonder drug Mounjaro/Zepbound shrinks breast cancer tumors
    Tuesday, July 15, 2025 from Cancer News -- ScienceDaily
    A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors. University of Michigan researchers...
  • Obesity is driving a hidden cancer epidemic—13 types and rising deaths nationwide
    Tuesday, July 15, 2025 from Cancer News -- ScienceDaily
    Obesity-related cancer deaths in the U.S. have tripled in just two decades, with women, older adults, and minority groups most affected. New research presented at ENDO 2025 highlights how obesity—linked to 13 different cancers—is now a...
  • Older adults with cancer prioritize life quality
    Monday, July 14, 2025 from Healio.com HEMATOLOGY ONCOLOGY RSS Feed
    CHICAGO — Nearly three-quarters of older adults with advanced cancer value quality of life over extending survival, according to study results presented at ASCO Annual Meeting. However, data showed that regardless of patient preference...
  • Obesity-related cancer deaths more than tripled from 1999 to 2020
    Sunday, July 13, 2025 from Healio.com HEMATOLOGY ONCOLOGY RSS Feed
    SAN FRANCISCO — Obesity-related cancer deaths increased more than threefold between 1999 and 2020, according to an analysis of the CDC WONDER database presented at ENDO 2025. Faizan Ahmed, MD, internal medicine resident at Hackensack...
  • Tirzepatide: The weight-loss drug that also shrinks breast tumors in mice
    Sunday, July 13, 2025 from Cancer News -- ScienceDaily
    In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant weight loss in obese mice but also slashed breast cancer tumor growth. The research, presented at ENDO 2025, links...
  • Can I trust my sunscreen? Choice test results have created uncertainty over SPF claims and lab testing process
    Saturday, July 12, 2025 from Cancer | The Guardian
    With Australia having one of the highest rates of skin cancer in the world, the consumer advocate group’s report left many worried and wondering about the brands they use Follow our Australia news live blog for latest updates Get our...
  • ‘Tremendous uncertainty’ for cancer research as US officials target mRNA vaccines
    Saturday, July 12, 2025 from Cancer | The Guardian
    Amid Trump cuts and state-level backlash, experts worry that progress in messenger RNA vaccines could stall As US regulators restrict Covid mRNA vaccines and as independent vaccine advisers re-examine the shots, scientists fear that an...
  • Breakthrough microchip reveals how your body fights viruses—in just 90 minutes
    Saturday, July 12, 2025 from Cancer News -- ScienceDaily
    A team at Scripps Research has created a microchip that can rapidly reveal how a person's antibodies respond to viruses using only a drop of blood. This game-changing technology, called mEM, condenses a week’s worth of lab work into 90...
  • AI has 'Iron Man suit' potential for clinicians in outpatient care
    Friday, July 11, 2025 from Healio.com HEMATOLOGY ONCOLOGY RSS Feed
    In the outpatient setting, some AI can help health care providers burdened by administrative work get back to what they got into medicine to do, according to experts at Cleveland Clinic’s AI Summit today. Currently, much of a health care...
  • Healio joins Cleveland Clinic’s A.I. Summit as official media partner
    Friday, July 11, 2025 from Healio.com HEMATOLOGY ONCOLOGY RSS Feed
    Healio announced an official media partnership with the Cleveland Clinic’s A.I. Summit for Healthcare Professionals, where Healio will unveil OncoIntel, a new tool for hematology and oncology HCPs that is set to launch this fall....
  • No cancer risk with long-term ixekizumab for psoriatic diseases
    Friday, July 11, 2025 from Healio.com HEMATOLOGY ONCOLOGY RSS Feed
    Incidences of malignant neoplasms were low and stable with long-term ixekizumab treatment for people with psoriatic disease and axial spondyloarthritis, according to findings from a pooled analysis. Chronic inflammation seen in psoriasis...
  • FDA Grants Accelerated Approval to Datopotamab Deruxtecan-dlnk for EGFR-mutated Non-Small Cell Lung Cancer
    Friday, July 11, 2025 from ESMO News
    Evidence for efficacy is based on the results from the TROPION-Lung05 and TROPION-Lung01 studies
  • Details of Julian McMahon’s cancer revealed a week after his death aged 56
    Thursday, July 10, 2025 from Cancer | The Guardian
    Charmed, Fantastic Four and Nip/Tuck actor’s cause of death was lung metastasis due to head and neck cancer Julian McMahon – a life in pictures Julian McMahon’s cause of death has been revealed, a little over a week after the Australian...
  • High-cost immunotherapy increases likelihood of financial hardship among cancer survivors
    Thursday, July 10, 2025 from Healio.com HEMATOLOGY ONCOLOGY RSS Feed
    Cancer survivors who received high-cost immunotherapies appear more likely to experience financial hardship, according to study results published in Journal of Cancer Survivorship. Financial hardship, including debt, inability to afford...
  • HHS cancels USPSTF meeting, raising concern among medical groups
    Thursday, July 10, 2025 from Healio.com HEMATOLOGY ONCOLOGY RSS Feed
    HHS abruptly canceled a U.S. Preventive Services Task Force meeting scheduled for today, leading some to question the future of its 16 members. HHS confirmed the cancelation to Healio but did not comment on whether the meeting would be...
  • 'We need to keep up': How PCPs can fight the rising tide of early-onset colorectal cancer
    Thursday, July 10, 2025 from Healio.com HEMATOLOGY ONCOLOGY RSS Feed
    As early-onset colorectal cancer cases rise, primary care providers can help young patients identify the first symptoms and save lives with timely screening, according to experts. Cases of early-onset colorectal cancer (CRC) are climbing...
  • Monarez a step closer to becoming CDC director
    Wednesday, July 9, 2025 from Healio.com HEMATOLOGY ONCOLOGY RSS Feed
    Senators voted along party lines Wednesday to advance the nomination of Susan Monarez, PhD, to be the next CDC director. The Senate’s Health, Education, Labor and Pensions (HELP) committee voted 12-11 in favor of sending the nomination...
  • AI model detects delirium among hospitalized older adults
    Wednesday, July 9, 2025 from Healio.com HEMATOLOGY ONCOLOGY RSS Feed
    An AI model designed to automate assessment of delirium risk increased the number of detected cases among hospitalized older adults, according to results of a quality improvement study. Use of the model, which alerts trained team members...
  • 6 questions physicians should ask before buying an AI product
    Wednesday, July 9, 2025 from Healio.com HEMATOLOGY ONCOLOGY RSS Feed
    More physicians than ever are turning to AI to improve efficiency — from administrative tasks to diagnosis and treatment — but it is important to do due diligence and fully understand an AI product before implementing it, experts said....
  • Expert: Antimicrobial resistance is a ‘cancer care crisis’
    Wednesday, July 9, 2025 from Healio.com HEMATOLOGY ONCOLOGY RSS Feed
    Many antimicrobial resistant pathogens are more prevalent in patients with cancer than in those without, even in the outpatient setting. A retrospective analysis found outpatients with cancer had higher prevalence of several WHO...
  • NHS pharmacies to pilot ‘sponge on a string’ test to spot cancer precursor
    Wednesday, July 9, 2025 from Cancer | The Guardian
    Scheme in England to identify signs of oesophageal cancer forms part of government’s 10-year health plan Hundreds of people in England are to be offered a “sponge on a string” test to identify a precursor to one of the deadliest cancers...
  • FDA approves SIR-Spheres for unresectable hepatocellular carcinoma
    Tuesday, July 8, 2025 from Healio.com HEMATOLOGY ONCOLOGY RSS Feed
    The FDA approved Y-90 resin microspheres for the treatment of unresectable hepatocellular carcinoma, according to a press release from the manufacturer. Y-90 resin microspheres (SIR-Spheres, Sirtex Medical) are a medical device...
  • ‘Healthy food matters’: Food insecurity increases mortality risk for cancer survivors
    Tuesday, July 8, 2025 from Healio.com HEMATOLOGY ONCOLOGY RSS Feed
    Patients with cancer who experience food insecurity have a significantly higher risk for death than those who have greater access to nutritional meals, according to results of a quantitative analysis. Food insecurity had a significant...
  • ‘Not just a physical issue’: CRC linked to adverse sexual health outcomes among women
    Tuesday, July 8, 2025 from Healio.com HEMATOLOGY ONCOLOGY RSS Feed
    Women with colorectal cancer appear to have higher risk for dyspareunia, pelvic inflammatory disease, endometriosis and premature ovarian failure compared with those without cancer, according to study results. These findings, published...
  • Private equity groups significantly raise colonoscopy prices at practices they acquire
    Tuesday, July 8, 2025 from Healio.com HEMATOLOGY ONCOLOGY RSS Feed
    Colonoscopy prices have increased significantly more at private equity-acquired gastroenterology practices compared with those at independent ones, according to results of a retrospective analysis. However, the quality of care remains...
  • Is exercise really better than drugs for cancer remission? It's an appealing idea – but it's misleading | Devi Sridhar
    Friday, July 4, 2025 from Cancer | The Guardian
    The healing power of exercise should never be underestimated, but be cautious about what recent headlines seem to suggest Prof Devi Sridhar is chair of global public health at the University of Edinburgh, and the author of How Not to Die...
  • Sweet-smelling molecule halts therapy-resistant pancreatic cancer
    Thursday, July 3, 2025 from Cancer News -- ScienceDaily
    A compound best known for giving almonds and apricots their aroma may be the key to defeating hard-to-kill cancer cells. Japanese researchers found that benzaldehyde can stop the shape-shifting ability of aggressive cancer cells, which...
  • The fatal mutation that lets cancer outsmart the human immune system
    Wednesday, July 2, 2025 from Cancer News -- ScienceDaily
    Scientists at UC Davis discovered a small genetic difference that could explain why humans are more prone to certain cancers than our primate cousins. The change affects a protein used by immune cells to kill tumors—except in humans,...
  • Air pollution linked to lung cancer-driving DNA mutations, study finds
    Wednesday, July 2, 2025 from Cancer | The Guardian
    Research finds that the higher the levels of air pollution in a region, the more cancer-promoting mutations are present Air pollution has been linked to a swathe of lung cancer-driving DNA mutations, in a study of people diagnosed with...
  • Women over 65 still at risk from cancer from HPV and should be offered cervical screening – study
    Tuesday, July 1, 2025 from Cancer | The Guardian
    Cases of cervical cancer among older people rising globally as research finds over-65s more likely to have HPV infections than younger women Routine cervical screening should be offered to women aged 65 and over as they are still at...
  • This virus infects millions—and we just discovered its secret weapon
    Monday, June 30, 2025 from Cancer News -- ScienceDaily
    Scientists have discovered a stealthy mechanism that cytomegalovirus (CMV)—the leading infectious cause of birth defects in the U.S.—uses to infiltrate blood vessel cells while evading immune detection. The virus forms a hidden protein...
  • [Articles] Hormone therapy use and young-onset breast cancer: a pooled analysis of prospective cohorts included in the Premenopausal Breast Cancer Collaborative Group
    Monday, June 30, 2025 from The Lancet Oncology
    Oestrogen hormone therapy use was inversely associated with young-onset breast cancer, and oestrogen plus progestin hormone therapy was associated with higher young-onset breast cancer incidence among women with intact uterus and...
  • [Correspondence] Bridging tumour classification and treatment
    Monday, June 30, 2025 from The Lancet Oncology
    We read with great interest Jennelle C Hodge and colleagues’ Comment on the WHO Classification of Tumours1 and wish to highlight the crucial need to bridge the growing gap between diagnostic classification and therapeutic access in the...
  • [Correspondence] Considerations for results of the patient-reported outcome analyses of the TALAPRO-2 trial
    Monday, June 30, 2025 from The Lancet Oncology
    Nobuaki Matsubara and colleagues1 and Andre P Fay and colleagues2 are to be congratulated for making the patient perspective an integral part of cancer drug development with patient-reported outcomes from the TALAPRO-2 trial.
  • [Correspondence] Real-world challenges and considerations in treating von Hippel-Lindau disease with HIF-2α inhibitors
    Monday, June 30, 2025 from The Lancet Oncology
    The 50-month follow-up of LITESPARK-004, reported by Ramaprasad Srinivasan and colleagues,1 marks a pivotal advance for von Hippel-Lindau disease, a rare syndrome with limited therapies. The findings on belzutifan's durable efficacy,...
  • [Correspondence] Real-world challenges and considerations in treating von Hippel-Lindau disease with HIF-2α inhibitors
    Monday, June 30, 2025 from The Lancet Oncology
    Ramaprasad Srinivasan and colleagues described good oncological outcomes coupled with acceptable toxicity following treatment with the hypoxia-inducible factor-2α (HIF-2α) inhibitor belzutifan for patients with von Hippel-Lindau...
  • [Correspondence] Real-world challenges and considerations in treating von Hippel-Lindau disease with HIF-2α inhibitors – Authors' reply
    Monday, June 30, 2025 from The Lancet Oncology
    We thank the authors of these Correspondence pieces for their interest in our Article.1
  • [Corrections] Correction to Lancet Oncol 2024; 25: 1614–24
    Monday, June 30, 2025 from The Lancet Oncology
    Hughes T, Harper A, Gupta S, et al. The current and future global burden of cancer among adolescents and young adults: a population-based study. Lancet Oncol 2024; 25: 1614–24—In this Article, figure 3 has been replaced with an updated...
  • [Corrections] Correction to Lancet Oncol 2025; 26: e46–54
    Monday, June 30, 2025 from The Lancet Oncology
    Romero Y, Tittenbrun Z, Trapani D, et al. The changing global landscape of national cancer control plans. Lancet Oncol 2025; 26: e46–54—In this Policy Review, the spelling of Maha Al-Ghafry's name was incorrect in the NCCP Global Review...
  • [Corrections] Correction to Lancet Oncol 2025; 26: 503–15
    Monday, June 30, 2025 from The Lancet Oncology
    Van Gorp T, Moore KN, Konecny GE, et al. Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a...
  • [Corrections] Correction to Lancet Oncol 2025; 26: 571–82
    Monday, June 30, 2025 from The Lancet Oncology
    Srinivasan R, Iliopoulos O, Beckermann KE, et al. Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 study. Lancet Oncol 2025; 26:...
  • [Corrections] Correction to Lancet Oncol 2025; 26: e320–30
    Monday, June 30, 2025 from The Lancet Oncology
    Villarreal-Garza C, Aranda-Gutierrez A, Gonzalez-Sanchez DG, et al. National cancer control plans in Latin America and the Caribbean: challenges and future directions. Lancet Oncol 2025; 26: e320–30—In this Policy Review, the spelling of...
  • [Corrections] Correction to Lancet Oncol 2025; 26: 924–35
    Monday, June 30, 2025 from The Lancet Oncology
    Reddy CL, Sousa C, Atun R. Benchmarking infrastructure for cancer control in Commonwealth countries: a population-based observational study. Lancet Oncol 2025; 26: 924–35—In this Article, Prof Rifat Atun should have had the additional...
  • [Perspectives] Solutions for tackling the global surgery crisis in west Africa
    Monday, June 30, 2025 from The Lancet Oncology
    The global surgical crisis has become one of the most discussed health topics since the Lancet Commission report published in 2015 because the need is massive, and the consequences are devastating both to countless personal lives and to...
  • Powered by Feed Informer